Selected research
Market Structure
Global Protein G Sepharose Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Protein G Sepharose market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Protein G Sepharose is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Protein G Sepharose include Merck, Thermo Fisher Scientific, Abcam, Calibre Scientific, Chondrex, SERVA Electrophoresis, Neo Biotech, Rockland and M&S TechnoSystems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Protein G Sepharose market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Protein G Sepharose and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Protein G Sepharose sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Protein G Sepharose market size, projected growth trends, production technologies, key applications, and end-use industries.
Protein G Sepharose Segment by Company
Merck
Thermo Fisher Scientific
Abcam
Calibre Scientific
Chondrex
SERVA Electrophoresis
Neo Biotech
Rockland
M&S TechnoSystems
MedChemExpress
Yeasen
TargetMol
bersee
Heyuan Liji
Fujian Herui biotechnology
Protein G Sepharose Segment by Type
Covalent Coupling Type
Non-covalent Adsorption Type
Protein G Sepharose Segment by Application
Antibody Purification
Biopharmaceutical and Vaccine Research and Development
Diagnostic Reagent Development
Proteomics Research
Others
Protein G Sepharose Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Protein G Sepharose market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Protein G Sepharose and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Protein G Sepharose.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Protein G Sepharose market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Protein G Sepharose manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein G Sepharose in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Protein G Sepharose in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Covalent Coupling Type
- Non-covalent Adsorption Type
Applications
- Antibody Purification
- Biopharmaceutical and Vaccine Research and Development
- Diagnostic Reagent Development
- Proteomics Research
- Others
Companies covered
- Merck
- Thermo Fisher Scientific
- Abcam
- Calibre Scientific
- Chondrex
- SERVA Electrophoresis
- Neo Biotech
- Rockland
- M&S TechnoSystems
- MedChemExpress
- Yeasen
- TargetMol
- bersee
- Heyuan Liji
- Fujian Herui biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Protein G Sepharose Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Protein G Sepharose Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Protein G Sepharose Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Protein G Sepharose Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Protein G Sepharose Market Dynamics
- 2.1 Protein G Sepharose Industry Trends
- 2.2 Protein G Sepharose Industry Drivers
- 2.3 Protein G Sepharose Industry Opportunities and Challenges
- 2.4 Protein G Sepharose Industry Restraints
3 Protein G Sepharose Market by Manufacturers
- 3.1 Global Protein G Sepharose Revenue by Manufacturers (2021-2026)
- 3.2 Global Protein G Sepharose Sales by Manufacturers (2021-2026)
- 3.3 Global Protein G Sepharose Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Protein G Sepharose Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Protein G Sepharose Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Protein G Sepharose Manufacturers, Product Type & Application
- 3.7 Global Protein G Sepharose Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Protein G Sepharose Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Protein G Sepharose Players Market Share by Revenue in 2025
- 3.8.3 2025 Protein G Sepharose Tier 1, Tier 2, and Tier 3
4 Protein G Sepharose Market by Type
- 4.1 Protein G Sepharose Type Introduction
- 4.1.1 Covalent Coupling Type
- 4.1.2 Non-covalent Adsorption Type
- 4.2 Global Protein G Sepharose Sales by Type
- 4.2.1 Global Protein G Sepharose Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Protein G Sepharose Sales by Type (2021-2032)
- 4.2.3 Global Protein G Sepharose Sales Market Share by Type (2021-2032)
- 4.3 Global Protein G Sepharose Revenue by Type
- 4.3.1 Global Protein G Sepharose Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Protein G Sepharose Revenue by Type (2021-2032)
- 4.3.3 Global Protein G Sepharose Revenue Market Share by Type (2021-2032)
5 Protein G Sepharose Market by Application
- 5.1 Protein G Sepharose Application Introduction
- 5.1.1 Antibody Purification
- 5.1.2 Biopharmaceutical and Vaccine Research and Development
- 5.1.3 Diagnostic Reagent Development
- 5.1.4 Proteomics Research
- 5.1.5 Others
- 5.2 Global Protein G Sepharose Sales by Application
- 5.2.1 Global Protein G Sepharose Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Protein G Sepharose Sales by Application (2021-2032)
- 5.2.3 Global Protein G Sepharose Sales Market Share by Application (2021-2032)
- 5.3 Global Protein G Sepharose Revenue by Application
- 5.3.1 Global Protein G Sepharose Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Protein G Sepharose Revenue by Application (2021-2032)
- 5.3.3 Global Protein G Sepharose Revenue Market Share by Application (2021-2032)
6 Global Protein G Sepharose Sales by Region
- 6.1 Global Protein G Sepharose Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Protein G Sepharose Sales by Region (2021-2032)
- 6.2.1 Global Protein G Sepharose Sales by Region (2021-2026)
- 6.2.2 Global Protein G Sepharose Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Protein G Sepharose Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Protein G Sepharose Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Protein G Sepharose Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Protein G Sepharose Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Protein G Sepharose Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Protein G Sepharose Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Protein G Sepharose Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Protein G Sepharose Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Protein G Sepharose Revenue by Region
- 7.1 Global Protein G Sepharose Revenue by Region
- 7.1.1 Global Protein G Sepharose Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Protein G Sepharose Revenue by Region (2021-2026)
- 7.1.3 Global Protein G Sepharose Revenue by Region (2027-2032)
- 7.1.4 Global Protein G Sepharose Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Protein G Sepharose Revenue (2021-2032)
- 7.2.2 North America Protein G Sepharose Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Protein G Sepharose Revenue (2021-2032)
- 7.3.2 Europe Protein G Sepharose Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Protein G Sepharose Revenue (2021-2032)
- 7.4.2 Asia-Pacific Protein G Sepharose Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Protein G Sepharose Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Protein G Sepharose Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Protein G Sepharose Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Thermo Fisher Scientific
- 8.2.1 Thermo Fisher Scientific Company Information
- 8.2.2 Thermo Fisher Scientific Business Overview
- 8.2.3 Thermo Fisher Scientific Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Scientific Protein G Sepharose Product Portfolio
- 8.2.5 Thermo Fisher Scientific Recent Developments
- 8.3 Abcam
- 8.3.1 Abcam Company Information
- 8.3.2 Abcam Business Overview
- 8.3.3 Abcam Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Abcam Protein G Sepharose Product Portfolio
- 8.3.5 Abcam Recent Developments
- 8.4 Calibre Scientific
- 8.4.1 Calibre Scientific Company Information
- 8.4.2 Calibre Scientific Business Overview
- 8.4.3 Calibre Scientific Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Calibre Scientific Protein G Sepharose Product Portfolio
- 8.4.5 Calibre Scientific Recent Developments
- 8.5 Chondrex
- 8.5.1 Chondrex Company Information
- 8.5.2 Chondrex Business Overview
- 8.5.3 Chondrex Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Chondrex Protein G Sepharose Product Portfolio
- 8.5.5 Chondrex Recent Developments
- 8.6 SERVA Electrophoresis
- 8.6.1 SERVA Electrophoresis Company Information
- 8.6.2 SERVA Electrophoresis Business Overview
- 8.6.3 SERVA Electrophoresis Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 SERVA Electrophoresis Protein G Sepharose Product Portfolio
- 8.6.5 SERVA Electrophoresis Recent Developments
- 8.7 Neo Biotech
- 8.7.1 Neo Biotech Company Information
- 8.7.2 Neo Biotech Business Overview
- 8.7.3 Neo Biotech Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Neo Biotech Protein G Sepharose Product Portfolio
- 8.7.5 Neo Biotech Recent Developments
- 8.8 Rockland
- 8.8.1 Rockland Company Information
- 8.8.2 Rockland Business Overview
- 8.8.3 Rockland Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Rockland Protein G Sepharose Product Portfolio
- 8.8.5 Rockland Recent Developments
- 8.9 M&S TechnoSystems
- 8.9.1 M&S TechnoSystems Company Information
- 8.9.2 M&S TechnoSystems Business Overview
- 8.9.3 M&S TechnoSystems Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 M&S TechnoSystems Protein G Sepharose Product Portfolio
- 8.9.5 M&S TechnoSystems Recent Developments
- 8.10 MedChemExpress
- 8.10.1 MedChemExpress Company Information
- 8.10.2 MedChemExpress Business Overview
- 8.10.3 MedChemExpress Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 MedChemExpress Protein G Sepharose Product Portfolio
- 8.10.5 MedChemExpress Recent Developments
- 8.11 Yeasen
- 8.11.1 Yeasen Company Information
- 8.11.2 Yeasen Business Overview
- 8.11.3 Yeasen Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Yeasen Protein G Sepharose Product Portfolio
- 8.11.5 Yeasen Recent Developments
- 8.12 TargetMol
- 8.12.1 TargetMol Company Information
- 8.12.2 TargetMol Business Overview
- 8.12.3 TargetMol Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 TargetMol Protein G Sepharose Product Portfolio
- 8.12.5 TargetMol Recent Developments
- 8.13 bersee
- 8.13.1 bersee Company Information
- 8.13.2 bersee Business Overview
- 8.13.3 bersee Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 bersee Protein G Sepharose Product Portfolio
- 8.13.5 bersee Recent Developments
- 8.14 Heyuan Liji
- 8.14.1 Heyuan Liji Company Information
- 8.14.2 Heyuan Liji Business Overview
- 8.14.3 Heyuan Liji Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Heyuan Liji Protein G Sepharose Product Portfolio
- 8.14.5 Heyuan Liji Recent Developments
- 8.15 Fujian Herui biotechnology
- 8.15.1 Fujian Herui biotechnology Company Information
- 8.15.2 Fujian Herui biotechnology Business Overview
- 8.15.3 Fujian Herui biotechnology Protein G Sepharose Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Fujian Herui biotechnology Protein G Sepharose Product Portfolio
- 8.15.5 Fujian Herui biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Protein G Sepharose Value Chain Analysis
- 9.1.1 Protein G Sepharose Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Protein G Sepharose Production Mode & Process
- 9.2 Protein G Sepharose Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Protein G Sepharose Distributors
- 9.2.3 Protein G Sepharose Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst